Central Serous Chorioretinopathy
Showing 1 - 25 of 48
Eplerenone, Aflibercept and Topical Nepafenac Serous Foveal Deta
Completed
- Central Serous Chorioretinopathy
- Eplerenone , Intravitreal Aflibercept and Topical nepafenac therapy
-
Cairo, EgyptKasr alainy faculty of medicine
May 5, 2023
Central Serous Chorioretinopathy Trial (100µm laser spot diameter micropulse laser, 200µm laser spot diameter micropulse laser)
Not yet recruiting
- Central Serous Chorioretinopathy
- 100μm laser spot diameter micropulse laser
- 200μm laser spot diameter micropulse laser
- (no location specified)
Jan 13, 2023
Age-Related Macular Degeneration, Diabetic Retinopathy, Central Serous Chorioretinopathy Trial in New York (OCT Imaging Using
Not yet recruiting
- Age-Related Macular Degeneration
- +5 more
- OCT Imaging Using Device N
- OCT Imaging Using Device C
-
New York, New YorkNYU Langone Health
Jan 6, 2023
Central Serous Chorioretinopathy Trial in Bordeaux (micropulse laser)
Not yet recruiting
- Central Serous Chorioretinopathy
- micropulse laser
-
Bordeaux, FranceCHU Bordeaux
Jan 9, 2023
Choroidal Blood Flow in Acute and Chronic Central Serous
Recruiting
- Central Serous Chorioretinopathy
-
Stavanger, NorwayStavanger University Hospital, Department of Ophthalmology
Oct 18, 2022
Central Serous Chorioretinopathy Trial in East Melbourne, Glen Iris (2RT subthreshold nanosecond laser - active, 2RT
Recruiting
- Central Serous Chorioretinopathy
- 2RT subthreshold nanosecond laser - active
- 2RT subthreshold nanosecond laser - sham
-
East Melbourne, Victoria, Australia
- +1 more
Oct 17, 2022
Central Serous Chorioretinopathy, Therapy, Photodynamic Trial in Beijing (50% dose of photodynamic therapy, 70% dose of
Recruiting
- Central Serous Chorioretinopathy
- Therapy, Photodynamic
- 50% dose of photodynamic therapy
- 70% dose of photodynamic therapy
-
Beijing, Beijing, ChinaPeking University People's Hospital
May 21, 2022
Central Serous Chorioretinopathy Trial in Hong Kong
Recruiting
- Central Serous Chorioretinopathy
-
Hong Kong, Hong Kong
- +2 more
Apr 19, 2022
Central Serous Chorioretinopathy, Irvine-Gass Syndrome, Pars Planitis Trial in Banha (Triamcinolone Acetonide)
Recruiting
- Central Serous Chorioretinopathy
- +3 more
- Triamcinolone Acetonide
-
Banhā, QA, EgyptAhmed Abdelshafy
Apr 13, 2022
Multiple Eye Fundus Diseases From Color Fundus Photograph
Completed
- Diabetic Retinopathy
- +12 more
- Software assisted imaging diagnosis
-
BeiJing, Beijing, China
- +4 more
Dec 28, 2021
Eplerenone Versus PDT: Comparative Study by OCTA
Completed
- Central Serous Chorioretinopathy
- Eplerenone
- The patients underwent half fluence photodynamic therapy for 6 months
- (no location specified)
Oct 21, 2021
OCT in Rare Chorioretinal Diseases
Recruiting
- Retinal Artery Occlusions
- +4 more
-
Portland, OregonCasey Eye Institute, Oregon Health & Science University
Jul 13, 2021
Central Serous Chorioretinopathy, Age Related Macular Degeneration, Idiopathic Poplypoidal Choroidal Vasculopathy Trial in
Recruiting
- Central Serous Chorioretinopathy
- +2 more
-
Toronto, Ontario, CanadaSunnybrook Research Institute
Jan 25, 2021
Pilot Study on Deep Learning in the Eye
Not yet recruiting
- Central Serous Chorioretinopathy
- +2 more
- Image classification using deep learning algorithm
- (no location specified)
Jan 5, 2021
Central Serous Chorioretinopathy, Chronic Central Serous Chorioretinopathy Trial in Ankara (Source of growth factors: autologous
Completed
- Central Serous Chorioretinopathy
- Chronic Central Serous Chorioretinopathy
- Source of growth factors: autologous platelet-rich plasma (aPRP) + repetitive electromagnetic stimulation for iontophoresis
-
Ankara, Türkiye, TurkeyAnkara University Biotechnology Institute
Jan 9, 2020
Macular Edema, Central Serous Chorioretinopathy, Retinal Vein Occlusion Trial in Bern (Selective retinal pigment epithelium
Suspended
- Macular Edema
- +4 more
- Selective retinal pigment epithelium laser therapy using the R:GEN Laser System
-
Bern, SwitzerlandDepartment of Ophthalmology, Bern University Hospital
Oct 9, 2019
Central Serous Chorioretinopathy Trial in Besançon (RTX1 IMAGIN EYE retinal camera)
Terminated
- Central Serous Chorioretinopathy
- RTX1 IMAGIN EYE retinal camera
-
Besançon, FranceCHU Besançon
Sep 13, 2019
Optical Coherence Tomography Angiography and Central Serous
Completed
- Central Serous Chorioretinopathy
- Optical Coherence Tomography Angiography (OCT-A)
- (no location specified)
May 10, 2019
Central Serous Chorioretinopathy Trial (Selective retina therapy)
Completed
- Central Serous Chorioretinopathy
- Selective retina therapy
- (no location specified)
Dec 29, 2018
Central Serous Chorioretinopathy Trial in Seongnam-si, Seoul (R:GEN Selective Retina Therapy)
Completed
- Central Serous Chorioretinopathy
- R:GEN Selective Retina Therapy
-
Seongnam-si, Korea, Republic of
- +5 more
Nov 28, 2018
Central Serous Chorioretinopathy Trial in United States (25mg Eplerenone, Placebo)
Completed
- Central Serous Chorioretinopathy
- 25mg Eplerenone
- Placebo
-
Cherry Hill, New Jersey
- +9 more
Oct 8, 2018
Retinal Capillaries After Half-dose PDT Measured by OCTA in Eyes
Unknown status
- Central Serous Chorioretinopathy
- Half-dose photodynamic therapy
-
Guangzhou, Guangdong, China
- +1 more
Sep 28, 2018
Central Serous Chorioretinopathy Trial in Buenos Aires, Tel Aviv (Brinzolamide Ophthalmic)
Unknown status
- Central Serous Chorioretinopathy
- Brinzolamide Ophthalmic
-
Buenos Aires, Argentina
- +1 more
May 29, 2018
Central Serous Chorioretinopathy Trial in Boston (Eplerenone 50mg)
Completed
- Central Serous Chorioretinopathy
- Eplerenone 50mg
-
Boston, MassachusettsNew England Eye Center / Tufts Medical Center
Apr 17, 2018
Central Serous Chorioretinopathy, Tomography, Optical Coherence Trial in Beijing (OCTA-guided Photodynamic therapy, ICGA-guided
Completed
- Central Serous Chorioretinopathy
- Tomography, Optical Coherence
- OCTA-guided Photodynamic therapy
- ICGA-guided Photodynamic therapy
-
Beijing, Beijing, ChinaPeople's Hospital of Peking University
Apr 14, 2018